Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.33 |
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1969360 | 0.92 | CA2 (0.37) | CA2TSHRKCNH3ALDH1A1POLB | |
| SCHEMBL8678984 | 0.88 | MAPK1 (0.39) | CA2KCNH3ALDH1A1POLBLMNA | |
| SCHEMBL5363348 | 0.83 | CA2 (0.41) | CA2TSHRKCNH3ALDH1A1POLB | |
| SCHEMBL19356701 | 0.83 | DUT (0.41) | CA2TSHRKCNH3ALDH1A1POLB | |
| SCHEMBL28808583 | 0.81 | MEN1 (0.36) | CA2KCNH3ALDH1A1POLBLMNA | |
| SCHEMBL9880244 | 0.81 | CA2 (0.40) | CA2TSHRKCNH3ALDH1A1POLB | |
| SCHEMBL9880245 | 0.81 | CA2 (0.40) | CA2TSHRKCNH3ALDH1A1POLB | |
| SCHEMBL30130340 | 0.80 | CA4 (0.33) | CA2KCNH3POLBCA4 | |
| SCHEMBL105659 | 0.80 | LMNA (0.39) | ALDH1A1LMNAHPGDMEN1KMT2A | |
| SCHEMBL11444489 | 0.79 | NCF1 (0.40) | TSHRALDH1A1TDP1MAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703866-B2 | Room temperature curable organopolysiloxane composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-04-22 | — | — | US | claimed |
| EP-0862187-B1 | Formulation for the insulating protection of electric conductors | SERVICIOS CONDUMEX SA (MX) | 2003-08-20 | — | — | EP | claimed |
| EP-3429980-B1 | SURFACE APPLIED CORROSION INHIBITOR | SIKA TECH AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-20260109109-A1 | ADDITIVE MANUFACTURING GUIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-3600892-B1 | METHOD OF FORMING POROUS THREE-DIMENSIONAL (3D) ARTICLE | DOW SILICONES CORP (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12606672-B2 | Curable composition | DAIKIN INDUSTRIES, LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-3790725-B1 | METHOD OF FORMING A THREE-DIMENSIONAL (3D) ARTICLE | DOW SILICONES CORP (US) | 2026-01-14 | — | — | EP | disclosed |
| US-12508556-B2 | Static mixer | DOW SILICONES CORPORATION (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4660250-A1 | ROOM-TEMPERATURE-CURABLE SILICONE COMPOSITION | Momentive Performance Materials Japan LLC (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-12458932-B2 | Filtration membrane | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-04 | — | — | US | disclosed |
| EP-4079787-B1 | CURABLE COMPOSITION | DAIKIN IND LTD (JP) | 2025-09-10 | — | — | EP | disclosed |
| EP-0074913-B1 | SOLVENTLESS COMPOSITIONS OF POLYSILOXANES WITH HYDROXYSILYL GROUPS AND RETICULATING AGENTS WITH ALKOXYSILYL GROUPS CATALYZED BY ORGANIC IRON OR ZIRCONIUM COMPOUNDS, THEIR USE IN IMPREGNATING OR COATING COMPOSITIONS FOR ASBEST, CELLULOSIC OR SYNTHETIC MATERIALS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1986-08-20 | — | — | EP | disclosed |
| US-4543381-A | Tree retardant additive composition for polymeric insulation | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1985-09-24 | — | — | US | disclosed |
| US-4404348-A | Solventless organosilicon coating/impregnating compositions | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-09-13 | — | — | US | disclosed |
| EP-0074913-A1 | Solventless compositions of polysiloxanes with hydroxysilyl groups and reticulating agents with alkoxysilyl groups catalyzed by organic iron or zirconium compounds, their use in impregnating or coating compositions for asbest, cellulosic or synthetic materials | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-03-23 | — | — | EP | disclosed |
| EP-0070786-A1 | Process for preparing moisture-curable organopolysiloxane compositions by condensing organosilicen compounds having silicon-bound hydroxyl groups, alkoxy-silylated cross-linking agents and a substitituted hydroxyl amine; compositions and their use in obtaining cured materials | RHONE-POULENC CHIMIE (FR) | 1983-01-26 | — | — | EP | disclosed |
| US-4299713-A | HIGH VOLTAGE CABLES | NATIONAL DISTILLERS AND CHEMICAL CORP. (US) | 1981-11-10 | — | — | US | disclosed |
| US-4143088-A | ORGANOSILICON COMPOUND, ORGANOTITANIUM COMPOUND | RHONE-POULENC INDUSTRIES (FR) | 1979-03-06 | — | — | US | disclosed |
| US-4064096-A | Curable, storage-stable liquid organopolysiloxane compositions | RHONE-POULENC INDUSTRIES (FR) | 1977-12-20 | — | — | US | disclosed |
| US-3965280-A | Use of organopolysiloxane compositions which cure at ambient temperature in coating electrical and electronic devices | RHONE-POULENC S.A. (FR) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606672-B2 | Curable composition | F8, CCNE2, PF4 | CA2 213/4885TSHR 1580/4885KCNH3 1295/4885 |
| US-12508556-B2 | Static mixer | CTNNA1, CTNND1, ARCN1 | CA2 4391/4885TSHR 1859/4885KCNH3 3764/4885 |
| US-20260109109-A1 | ADDITIVE MANUFACTURING GUIDE | HTR3D, SMCHD1, SMC3 | CA2 3654/4885TSHR 3681/4885KCNH3 3636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.